Arjun has grown several VC-backed and PE-owned companies within technology, healthcare, and life sciences.

He helped scale a diagnostics business to a listing on the NASDAQ. He was the Chief Strategy Officer and SVP Operations at Prenetics EMEA, delivering >3m COVID-19 tests and managing a $150m P&L. Prior to this, as the CEO of Oxsed, a subsidiary acquired from Oxford University, he built leading R&D capabilities before integrating the company into the Group.

Arjun is passionate about advancing innovation in healthcare. As an Interim, he developed the growth strategy for health ventures at Sciensus, Gousto, Cyted and Sight Diagnostics. And as a Founding Member of GP at Hand, he helped launch the largest NHS primary care service at Babylon, a pioneer in digital health.

Arjun qualified as a medical doctor from Manchester Medical School, trained in investment management at BlackRock, and worked in venture capital at Oxford Science Enterprises. As an Interim, he is currently leading transformation at Optasia, a FinTech serving >100m consumers across >40 countries.